ABSTRACT
The success of phytomedine or herbal drug development is linked to the production of good quality plants as per requirement. For using plant-based conventional natural product drugs also, the availability of uniform high-quality plant raw materials as and when needed is very crucial. When a plant is found very promising in the preliminary screening, target plant collection in bulk quantity may be a problem in certain cases due to limited availability of plant biomass, scattered distribution, inconsistent efcacy, and so on.
